ATE323176T1 - Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen - Google Patents

Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen

Info

Publication number
ATE323176T1
ATE323176T1 AT96943485T AT96943485T ATE323176T1 AT E323176 T1 ATE323176 T1 AT E323176T1 AT 96943485 T AT96943485 T AT 96943485T AT 96943485 T AT96943485 T AT 96943485T AT E323176 T1 ATE323176 T1 AT E323176T1
Authority
AT
Austria
Prior art keywords
breast cancer
sequences
detection
tumor virus
human
Prior art date
Application number
AT96943485T
Other languages
English (en)
Inventor
James F Holland
Beatriz G T Pogo
Original Assignee
James F Holland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James F Holland filed Critical James F Holland
Application granted granted Critical
Publication of ATE323176T1 publication Critical patent/ATE323176T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96943485T 1995-11-09 1996-11-08 Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen ATE323176T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/555,394 US5686247A (en) 1995-11-09 1995-11-09 Detection of mammary tumor virus env gene-like sequences in human breast cancer

Publications (1)

Publication Number Publication Date
ATE323176T1 true ATE323176T1 (de) 2006-04-15

Family

ID=24217097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943485T ATE323176T1 (de) 1995-11-09 1996-11-08 Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen

Country Status (8)

Country Link
US (2) US5686247A (de)
EP (1) EP0866878B1 (de)
JP (1) JP2000500650A (de)
AT (1) ATE323176T1 (de)
AU (1) AU717291B2 (de)
CA (1) CA2236837C (de)
DE (1) DE69636041T2 (de)
WO (1) WO1997017470A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040176314A1 (en) * 1997-07-07 2004-09-09 Bio Merieux Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
AU8571598A (en) * 1997-07-17 1999-02-10 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
CN1305384A (zh) * 1998-04-08 2001-07-25 国际生物免疫系统公司 Mmtv抗原的免疫调节组合物及其使用方法
US6686147B1 (en) 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
CA2369848C (en) 1999-06-30 2011-09-20 Robert F. Garry Human endogenous retrovirus in breast cancer
WO2005073728A1 (en) * 2004-01-29 2005-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for diagnosing and treatment of breast cancer and pharmaceuticals copmsition and kit for same
US8093063B2 (en) * 2007-11-29 2012-01-10 Quest Diagnostics Investments Incorporated Assay for detecting genetic abnormalities in genomic nucleic acids
WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY
EP4038222A4 (de) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Verfahren und zusammensetzungen zur identifizierung von neoantigenen zur verwendung bei der behandlung und vorbeugung von krebs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707438A (en) * 1984-08-22 1987-11-17 Tel Aviv University Immunoassay for breast cancer employing monoclonal antibodies

Also Published As

Publication number Publication date
DE69636041D1 (de) 2006-05-24
EP0866878A1 (de) 1998-09-30
DE69636041T2 (de) 2006-11-23
US6040146A (en) 2000-03-21
CA2236837A1 (en) 1997-05-15
JP2000500650A (ja) 2000-01-25
EP0866878B1 (de) 2006-04-12
WO1997017470A1 (en) 1997-05-15
AU1271497A (en) 1997-05-29
EP0866878A4 (de) 2002-02-13
CA2236837C (en) 2009-01-27
US5686247A (en) 1997-11-11
AU717291B2 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
EP1870466A3 (de) Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Prostatakrebs
AU9021898A (en) Prostate tumor polynucleotide and antigen compositions
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
TR200201567T2 (tr) Kızılötesine yakın ışık bölgesinde aktif fluoresan kontrast maddesi ve fluoresans görüntü alma.
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
SE8902532D0 (sv) Bestaemning av plasmaproteiner
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
DE69605908D1 (de) Benutzung von reagenzien abgeleitet vom menschlichen metastase unterdrückungs gen kai1 in diagnostischen und gen-terapeutischen verfahren
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
EA200000845A1 (ru) Ген, кодирующий новый маркер рака
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
ATE266203T1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
ATE406178T1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
DE69827805D1 (de) Verfahren und vorrichtung zur bestimmung des transformationspotentials von verbindungen.
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
DE68929511D1 (de) Nachweis, Quantifizierung und Klassifizierung von RAS-Proteinen in Körperflüssigkeiten und Geweben
ATE267253T1 (de) Von htlv-i und htlv-ii gp21 abgeleitete peptide zur diagnostischen verwendung
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
DE69628659D1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
FI953364A0 (fi) Kehon nesteistä tai kudoksista uutettujen synteettisten oligonukleotidien toteaminen
WO2002054079A3 (en) Proteins, genes and their use for diagnosis and treatment of cardiac response

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties